<--- Back to Details
First PageDocument Content
Research / Design of experiments / Pharmacology / Epidemiology / Pharmaceutical industry / Clinical trial / Randomized controlled trial / Food and Drug Administration / Bayesian inference / Statistics / Clinical research / Science
Date: 2005-03-16 08:49:42
Research
Design of experiments
Pharmacology
Epidemiology
Pharmaceutical industry
Clinical trial
Randomized controlled trial
Food and Drug Administration
Bayesian inference
Statistics
Clinical research
Science

FDA Executive Summary Supplement Statistical Issues The sponsor provided more data from the AKH Registry and presented the results from a Bayesian analysis of the data. FDA reviewed this information below are issues iden

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 128,94 KB

Share Document on Facebook

Similar Documents

Aquis Exchange Monthly Statistics Feb-2017 € 13,938,544,778 1,068,768,383  Value Traded

Aquis Exchange Monthly Statistics Feb-2017 € 13,938,544,778 1,068,768,383 Value Traded

DocID: 1xVY0 - View Document

Aquis Exchange Monthly Statistics Feb-2016 € 5,995,146,,183,444  Nestle SA

Aquis Exchange Monthly Statistics Feb-2016 € 5,995,146,,183,444 Nestle SA

DocID: 1xVWK - View Document

Aquis Exchange Monthly Statistics Feb-2018 € 17,012,038,916 1,321,056,240  Nestle SA

Aquis Exchange Monthly Statistics Feb-2018 € 17,012,038,916 1,321,056,240 Nestle SA

DocID: 1xVRB - View Document

Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455  Novartis AG

Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455 Novartis AG

DocID: 1xVO3 - View Document

Aquis Exchange Monthly Statistics Month: Value traded (EUR): Volume (no. of shares):  Jun-2017

Aquis Exchange Monthly Statistics Month: Value traded (EUR): Volume (no. of shares): Jun-2017

DocID: 1xVNh - View Document